Insider Transactions in Q4 2024 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
30,000
-1.8%
|
$330,000
$11.33 P/Share
|
|
Dec 11
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.67%
|
$990,000
$11.65 P/Share
|
|
Dec 10
2024
|
Sebastian Burzacchi COO - Mgmt Services Org |
SELL
Open market or private sale
|
Direct |
8,550
-3.78%
|
$94,050
$11.26 P/Share
|
|
Dec 05
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,574
-11.74%
|
$750,888
$12.2 P/Share
|
|
Nov 27
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
35,000
-9.85%
|
$420,000
$12.8 P/Share
|
|
Nov 22
2024
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
30,000
-1.77%
|
-
|
|
Nov 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
30,000
-1.74%
|
$330,000
$11.35 P/Share
|
|
Nov 11
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
30,500
-24.71%
|
$396,500
$13.42 P/Share
|
|
Nov 11
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
6,920
-0.61%
|
$89,960
$13.73 P/Share
|
|
Nov 11
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.54%
|
$1,170,000
$13.42 P/Share
|
|
Nov 04
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
20,500
-5.45%
|
$266,500
$13.06 P/Share
|
|
Nov 01
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,500
-1.18%
|
$54,000
$12.98 P/Share
|
|
Oct 31
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
36,197
-22.68%
|
$434,364
$12.04 P/Share
|
|
Oct 29
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
4,483
-2.73%
|
$53,796
$12.01 P/Share
|
|
Oct 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
30,000
-1.71%
|
$300,000
$10.77 P/Share
|
|
Oct 14
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
30,500
-15.67%
|
$335,500
$11.5 P/Share
|
|
Oct 09
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.42%
|
$990,000
$11.33 P/Share
|
|
Oct 08
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
39,320
-16.81%
|
$471,840
$12.04 P/Share
|
|
Oct 08
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,460
-4.04%
|
$247,060
$11.03 P/Share
|
|
Oct 02
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
9,125
-3.75%
|
$100,375
$11.01 P/Share
|
|
Oct 01
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
21,375
-4.13%
|
$213,750
$10.75 P/Share
|
|
Oct 01
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
667
-0.18%
|
$7,337
$11.79 P/Share
|